These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31690163)

  • 1. Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Xenobiotica; 2020 Jun; 50(6):733-740. PubMed ID: 31690163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement.
    Kazmi F; Barbara JE; Yerino P; Parkinson A
    Drug Metab Dispos; 2015 Apr; 43(4):523-33. PubMed ID: 25595597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine.
    Ghosal A; Yuan Y; Hapangama N; Su AD; Alvarez N; Chowdhury SK; Alton KB; Patrick JE; Zbaida S
    Biopharm Drug Dispos; 2004 Sep; 25(6):243-52. PubMed ID: 15334623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver.
    Kato S; Shah A; Plesescu M; Miyata Y; Bolleddula J; Chowdhury S; Zhu X
    Drug Metab Dispos; 2020 Oct; 48(10):934-943. PubMed ID: 32665417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in high-resolution MS and hepatocyte models solve a long-standing metabolism challenge: the loratadine story.
    Aratyn-Schaus Y; Ramanathan R
    Bioanalysis; 2016 Aug; 8(16):1645-62. PubMed ID: 27460981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further Characterization of the Metabolism of Desloratadine and Its Cytochrome P450 and UDP-glucuronosyltransferase Inhibition Potential: Identification of Desloratadine as a Relatively Selective UGT2B10 Inhibitor.
    Kazmi F; Yerino P; Barbara JE; Parkinson A
    Drug Metab Dispos; 2015 Sep; 43(9):1294-302. PubMed ID: 26135009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult and paediatric poor metabolisers of desloratadine: an assessment of pharmacokinetics and safety.
    Prenner B; Kim K; Gupta S; Khalilieh S; Kantesaria B; Manitpisitkul P; Lorber R; Wang Z; Lutsky B
    Expert Opin Drug Saf; 2006 Mar; 5(2):211-23. PubMed ID: 16503743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of loratadine in male and female mice, rats and monkeys.
    Ramanathan R; Alvarez N; Su AD; Chowdhury S; Alton K; Stauber K; Patrick J
    Xenobiotica; 2005 Feb; 35(2):155-89. PubMed ID: 16019945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Aldehyde Oxidase 1-Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes.
    Uehara S; Yoneda N; Higuchi Y; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2020 Jul; 48(7):580-586. PubMed ID: 32357972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte spheroids as a viable
    Chacko SA; Ly VT; Christopher LJ; Gan J
    Xenobiotica; 2020 Jun; 50(6):621-629. PubMed ID: 31566996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In Humans.
    Itkonen MK; Tornio A; Neuvonen M; Neuvonen PJ; Niemi M; Backman JT
    Drug Metab Dispos; 2019 Apr; 47(4):377-385. PubMed ID: 30630815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Unique Human N10-Glucuronidated Metabolite Formation from Olanzapine in Chimeric NOG-TKm30 Mice with Humanized Livers.
    Uehara S; Higuchi Y; Yoneda N; Kato H; Yamazaki H; Suemizu H
    Drug Metab Dispos; 2023 Apr; 51(4):480-491. PubMed ID: 36623885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
    Molimard M; Diquet B; Benedetti MS
    Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orthogonal extraction/chromatography and UPLC, two powerful new techniques for bioanalytical quantitation of desloratadine and 3-hydroxydesloratadine at 25 pg/mL.
    Shen JX; Wang H; Tadros S; Hayes RN
    J Pharm Biomed Anal; 2006 Feb; 40(3):689-706. PubMed ID: 16095862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictability of human pharmacokinetics of diisononyl phthalate (DINP) using chimeric mice with humanized liver.
    Iwata H; Goto M; Sakai N; Suemizu H; Yamazaki H
    Xenobiotica; 2019 Nov; 49(11):1311-1322. PubMed ID: 30589368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human urine and plasma concentrations of bisphenol A extrapolated from pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and semi-physiological pharmacokinetic modeling.
    Miyaguchi T; Suemizu H; Shimizu M; Shida S; Nishiyama S; Takano R; Murayama N; Yamazaki H
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):71-6. PubMed ID: 25805149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of loratadine and further characterization of its in vitro metabolites.
    Ghosal A; Gupta S; Ramanathan R; Yuan Y; Lu X; Su AD; Alvarez N; Zbaida S; Chowdhury SK; Alton KB
    Drug Metab Lett; 2009 Aug; 3(3):162-70. PubMed ID: 19702548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Desloratadine Slow-metabolizer Phenotype and Food-dependent Pharmacokinetics of Desloratadine in Healthy Chinese Volunteers.
    Wang T; Zhang K; Li T; He L; Xie H; Jiang X; Wang L
    Clin Drug Investig; 2015 Dec; 35(12):807-13. PubMed ID: 26446005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.